Compliance and viewpoint of glaucoma patients in Greece AGP Konstas, G Maskaleris, S Gratsonidis, C Sardelli Eye 14 (5), 752-756, 2000 | 221 | 2000 |
Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open‐labeled randomized trial M Chourdakis, MM Kraus, T Tzellos, C Sardeli, M Peftoulidou, ... Journal of Parenteral and Enteral Nutrition 36 (1), 108-116, 2012 | 151 | 2012 |
Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta‐analysis TG Tzellos, C Sardeli, A Lallas, G Papazisis, M Chourdakis, D Kouvelas Journal of the European Academy of Dermatology and Venereology 25 (3), 345-353, 2011 | 89 | 2011 |
PDE5 inhibitors: in vitro and in vivo pharmacological profile D Kouvelas, A Goulas, G Papazisis, C Sardeli, C Pourzitaki Current pharmaceutical design 15 (30), 3464-3475, 2009 | 79 | 2009 |
Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review I Tsakiridis, V Bousi, T Dagklis, C Sardeli, V Nikolopoulou, G Papazisis Archives of gynecology and obstetrics 300, 849-859, 2019 | 78 | 2019 |
Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia–ischemia G Papazisis, C Pourzitaki, C Sardeli, A Lallas, E Amaniti, D Kouvelas Pharmacological Research 57 (1), 73-78, 2008 | 72 | 2008 |
A2δ ligands gabapentin and pregabalin: future implications in daily clinical practice DK TG Tzellos, G Papazisis, KA Toulis, Ch Sardeli Hippokratia 14 (2), 71, 2010 | 48 | 2010 |
The role of sarcosine, uracil, and kynurenic acid metabolism in urine for diagnosis and progression monitoring of prostate cancer G Gkotsos, C Virgiliou, I Lagoudaki, C Sardeli, N Raikos, G Theodoridis, ... Metabolites 7 (1), 9, 2017 | 47 | 2017 |
Pregabalin abuse after past substance-seeking behavior. G Papazisis, G Garyfallos, C Sardeli, D Kouvelas International journal of clinical pharmacology and therapeutics 51 (5), 441-442, 2013 | 39 | 2013 |
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases P Zarogoulidis, P Chinelis, A Athanasiadou, T Tsiouda, G Trakada, ... Respiratory medicine case reports 22, 101-105, 2017 | 34 | 2017 |
Antidepressants on multiple sclerosis: a review of in vitro and in vivo models E Stamoula, S Siafis, I Dardalas, A Ainatzoglou, A Matsas, T Athanasiadis, ... Frontiers in Immunology 12, 677879, 2021 | 29 | 2021 |
α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction C Li, Y Shi, W Wang, C Sardeli, TH Kwon, K Thomsen, T Jonassen, ... American Journal of Physiology-Renal Physiology 290 (2), F384-F396, 2006 | 28 | 2006 |
Outcome of site-specific fascia repair for rectocele C Sardeli, SM Axelsen, D Kjær, KM Bek Acta obstetricia et gynecologica Scandinavica 86 (8), 973-977, 2007 | 26 | 2007 |
Use of porcine small intestinal submucosa in the surgical treatment of recurrent rectocele in a patient with Ehlers–Danlos syndrome type III C Sardeli, SM Axelsen, KM Bek International Urogynecology Journal 16, 504-505, 2005 | 25 | 2005 |
Pharmacologic and non-pharmacologic interventions for HIV-neuropathy pain. A systematic review and a meta-analysis A Amaniti, C Sardeli, V Fyntanidou, P Papakonstantinou, I Dalakakis, ... Medicina 55 (12), 762, 2019 | 24 | 2019 |
Inhaled cisplatin for NSCLC: facts and results C Kosmidis, K Sapalidis, P Zarogoulidis, C Sardeli, C Koulouris, ... International Journal of Molecular Sciences 20 (8), 2005, 2019 | 22 | 2019 |
Inhaled chemotherapy adverse effects: mechanisms and protection methods C Sardeli, P Zarogoulidis, C Kosmidis, A Amaniti, A Katsaounis, ... Lung Cancer Management 8 (4), LMT19, 2019 | 18 | 2019 |
Sex differences and adverse effects between chemotherapy and immunotherapy for non-small cell lung cancer T Tsiouda, C Sardeli, K Porpodis, M Pilikidou, G Apostolidis, K Kyrka, ... Journal of Cancer 11 (11), 3407, 2020 | 17 | 2020 |
EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE® K Sapalidis, P Zarogoulidis, D Petridis, C Kosmidis, B Fyntanidou, ... Journal of Cancer 10 (20), 4739, 2019 | 17 | 2019 |
Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1≥ 50% P Zarogoulidis, V Papadopoulos, E Maragouli, G Papatsibas, C Sardeli, ... Translational Lung Cancer Research 7 (Suppl 1), S28, 2018 | 17 | 2018 |